OVARIAN ENDOMETRIOID ADENOCARCINOMA
Clinical trials for OVARIAN ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer vaccine shows promise in small safety trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a custom-made vaccine for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine was made from each patient's own white blood cells and designed to train the immune system to attack cancer cells. The main goal was to …
Matched conditions: OVARIAN ENDOMETRIOID ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:40 UTC
-
Could a diabetes drug boost chemo for ovarian cancer?
Disease control CompletedThis study tested whether adding metformin (a common diabetes drug) to standard chemotherapy could help people with advanced ovarian, fallopian tube, or primary peritoneal cancer. About 111 participants received either metformin or a placebo alongside chemo, then continued metfor…
Matched conditions: OVARIAN ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:06 UTC